727 related articles for article (PubMed ID: 27697312)
1. Myopathy in Childhood Muscle-Specific Kinase Myasthenia Gravis.
Kirzinger L; Khomenko A; Schulte-Mattler W; Backhaus R; Platen S; Schalke B
Pediatr Neurol; 2016 Dec; 65():90-92. PubMed ID: 27697312
[TBL] [Abstract][Full Text] [Related]
2. Muscle-Specific Kinase Autoimmune Myasthenia Gravis: Report of a Pediatric Case and Literature Review.
Ben Younes T; Benrhouma H; Klaa H; Ben Aoun R; Rouissi A; Ben Ahmed M; Kraoua I; Ben Youssef-Turki I
Neuropediatrics; 2019 Apr; 50(2):116-121. PubMed ID: 30577044
[TBL] [Abstract][Full Text] [Related]
3. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.
Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA
Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia gravis with muscle-specific tyrosine kinase antibodies: A narrative review.
Morren J; Li Y
Muscle Nerve; 2018 Sep; 58(3):344-358. PubMed ID: 29461627
[TBL] [Abstract][Full Text] [Related]
5. AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review.
Lu Y; Ran H; Yang W; Ma Q; Qiu L; Ou C; Chen P; Lin Z; Liu W
Neuromuscul Disord; 2020 Jul; 30(7):534-538. PubMed ID: 32387283
[TBL] [Abstract][Full Text] [Related]
6. ["Seronegative" myasthenia with antibodies against muscle-specific tyrosine-kinase].
Hain B; Hanisch F; Deschauer M
Nervenarzt; 2004 Apr; 75(4):362-7. PubMed ID: 15042294
[TBL] [Abstract][Full Text] [Related]
7. Myopathy, muscle atrophy and tongue lipid composition in MuSK myasthenia gravis.
Nikolić AV; Bačić GG; Daković MŽ; Lavrnić SĐ; Rakočević Stojanović VM; Basta IZ; Lavrnić DV
Acta Neurol Belg; 2015 Sep; 115(3):361-5. PubMed ID: 25253293
[TBL] [Abstract][Full Text] [Related]
8. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study.
Modoni A; Mastrorosa A; Spagni G; Evoli A
Clin Neurophysiol; 2021 Aug; 132(8):1845-1849. PubMed ID: 34147009
[TBL] [Abstract][Full Text] [Related]
10. 3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies.
Evoli A; Alboini PE; Damato V; Iorio R
Neurology; 2016 Mar; 86(11):1070-1. PubMed ID: 26873957
[No Abstract] [Full Text] [Related]
11. Circulating microRNA plasma profile in MuSK+ myasthenia gravis.
Sabre L; Guptill JT; Russo M; Juel VC; Massey JM; Howard JF; Hobson-Webb LD; Punga AR
J Neuroimmunol; 2018 Dec; 325():87-91. PubMed ID: 30316681
[TBL] [Abstract][Full Text] [Related]
12. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
[TBL] [Abstract][Full Text] [Related]
13. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
14. Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies.
Rajakulendran S; Viegas S; Spillane J; Howard RS
J Neurol; 2012 Dec; 259(12):2736-9. PubMed ID: 22955633
[No Abstract] [Full Text] [Related]
15. A novel MuSK cell-based myasthenia gravis diagnostic assay.
Han J; Zhang J; Li M; Zhang Y; Lv J; Zhao X; Wang S; Wang L; Yang H; Han S; Fang H; Gao F
J Neuroimmunol; 2019 Dec; 337():577076. PubMed ID: 31655425
[TBL] [Abstract][Full Text] [Related]
16. Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles.
Kuwabara S; Nemoto Y; Misawa S; Takahashi H; Kawaguchi N; Hattori T
Acta Neurol Scand; 2007 Feb; 115(2):126-8. PubMed ID: 17212617
[TBL] [Abstract][Full Text] [Related]
17. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
McConville J; Farrugia ME; Beeson D; Kishore U; Metcalfe R; Newsom-Davis J; Vincent A
Ann Neurol; 2004 Apr; 55(4):580-4. PubMed ID: 15048899
[TBL] [Abstract][Full Text] [Related]
18. MuSK antibody positive myasthenia gravis in a 38-year old West Indian female.
Ramcharan K; Bahall M; Bodoe C; Khan S; Ewe P; Sharma S
West Indian Med J; 2011 Dec; 60(6):694-5. PubMed ID: 22512235
[No Abstract] [Full Text] [Related]
19. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo.
Benveniste O; Jacobson L; Farrugia ME; Clover L; Vincent A
J Neuroimmunol; 2005 Dec; 170(1-2):41-8. PubMed ID: 16213598
[TBL] [Abstract][Full Text] [Related]
20. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
Caress JB; Hunt CH; Batish SD
Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
